Leptin is suggested to be an independent predictor of future cardiovascular events, and patients with lower adiponectin levels are at risk of coronary heart disease, type 2 diabetes, hypertension, and dyslipidemia [39,40]. The gene discussed is ADIPOQ; the disease is type 2 diabetes mellitus.